| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
ADARx Pharmaceuticals, Inc.
13G
ADRX · 00654F105
|
11.1% |
10/16/2026
Event 9/30/2026
|
||||
| LAV Biosciences Fund V, L.P. | 10.5% | |||||
| LAV Fund VI, L.P. | 0.3% | |||||
| LAV Fund VI Opportunities, L.P. | 0.3% | |||||
| Yi Shi | 11.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.